Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Immunogen sequence: HGAKEDFHPP AEDWKPQSSH WGAALKDLHR IYRPMIGKLK FFIDEKYKIA DTSEGGIYLG FYEKQEVAVK TFCEGSPRAQ REVSCLQSSR ENSHLVTFYG SESHRGHLFV CVTLCEQTLE ACLDVHRGED VENEEDEFAR NVLSSI
Highest antigen sequence indentity to the following orthologs: Mouse - 58%, Rat - 58%.
A virally induced endoribonuclease, RNase L is the terminal factor of the anti-viral action of interferon. Activation of RNase L results in inhibition of viral proliferation. Activation of RNase L has also been determined to degrade RNA, thus, initiating a cellular stress response, inducing apoptosis. Since mutations in RNase L relate to an increased incidence of prostate cancer, the activation of RNase L functions in counteracting prostate cancer, via apoptosis.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: 2-5A-dependent ribonuclease; 2-5A-dependent RNase; Ribonuclease 4; Ribonuclease L; RNase L
基因别名: RNASEL; RNS4
Entrez Gene ID: (Human) 6041